BCRX
BioCryst Pharmaceuticals (BCRX)
$41
About BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Details
Daily high
$7.56
Daily low
$7.19
Price at open
$7.24
52 Week High
$11.31
52 Week Low
$6.00
Market cap
1.6B
Dividend yield
0.00%
Volume
6.2M
Avg. volume
4.2M
P/E ratio
-156.66
BioCryst Pharmaceuticals News
Details
Daily high
$7.56
Daily low
$7.19
Price at open
$7.24
52 Week High
$11.31
52 Week Low
$6.00
Market cap
1.6B
Dividend yield
0.00%
Volume
6.2M
Avg. volume
4.2M
P/E ratio
-156.66